RPL17 and ovarian carcinoma: Ovarian cancer exhibits a range of immunosuppressive mechanisms, such as overexpression of immune checkpoint molecules such as PD-1/PD-L1 (27), which suppress the immune system and help the cancer resist conventional therapies.